This could be an indication that plasma levels of VEGF-C/sVEGFR-3 may correlate with disease progression in LF leading to lymphatic dilation and lymphedema development and hence, might be developed as prognostic indicators of an increased risk of LF pathology before it actually becomes manifest. The gene discussed is VEGFC; the disease is Lassa fever.